You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Details for Patent: 9,669,021


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,669,021 protect, and when does it expire?

Patent 9,669,021 protects KYNMOBI and is included in one NDA.

This patent has forty-seven patent family members in nineteen countries.

Summary for Patent: 9,669,021
Title:Sublingual apomorphine
Abstract: Disclosed are methods of treating Parkinson's disease by (i) providing a pharmaceutical composition in unit dosage form that is a film having a first portion including apomorphine particles containing an acid addition salt of apomorphine and a second portion containing a pH neutralizing agent, where the film contains the acid addition salt of apomorphine in an amount effective to treat Parkinson's disease, and (ii) administering the film by placing the film sublingually in the mouth of the subject and contacting sublingual mucosal tissue with the film.
Inventor(s): Giovinazzo; Anthony John (Caledon, CA), Hedden; David Bruce (Ann Arbor, MI), De Somer; Marc L. (Winchester, MA), Bryson; Nathan John (Toronto, CA)
Assignee: Sunovion Pharmaceuticals Inc. (Marlborough, MA)
Application Number:14/971,532
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 9,669,021: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 9,669,021, focusing on its claims, scope, and the broader patent landscape.

Overview of the Patent

Patent Title and Description

United States Patent 9,669,021, titled "Sublingual Apomorphine," pertains to methods and compositions for treating Parkinson's disease. The patent describes a pharmaceutical composition in the form of a film designed for sublingual administration of apomorphine, a dopamine agonist used to manage Parkinson's symptoms[5].

Claims Analysis

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims define the broadest scope of the invention, while dependent claims narrow down the scope by adding additional limitations.

  • Independent Claims: These claims outline the core elements of the invention, such as the composition of the sublingual film, the method of administration, and the therapeutic effect of apomorphine.
  • Dependent Claims: These claims build upon the independent claims by specifying additional features, such as the dosage form, the presence of specific excipients, and the method of manufacturing the film.

Claim Construction

Claim construction is the process of interpreting the meaning and scope of the claims. This is critical for determining the patent's validity and enforceability. For example, the claims in US 9,669,021 might be construed to include specific formulations of apomorphine, the thickness of the sublingual film, or the method of dissolving the film under the tongue.

Scope of the Patent

Patent Scope and Coverage

The scope of the patent defines what is protected by the patent. For US 9,669,021, this includes:

  • Composition of Matter: The specific formulation of the sublingual film containing apomorphine.
  • Method of Use: The method of administering the film sublingually to treat Parkinson's disease.
  • Manufacturing Process: The process of creating the sublingual film, including the materials and steps involved.

Limitations and Exclusions

Understanding the limitations and exclusions of the patent is equally important. For instance, the patent may not cover other forms of apomorphine administration (e.g., injectable or oral tablets) or other treatments for Parkinson's disease that do not involve sublingual films.

Patent Landscape

Prior Art and Related Patents

To understand the novelty and non-obviousness of US 9,669,021, it is essential to review prior art and related patents. This can be done using resources such as the USPTO's Patent Public Search tool or international databases like the European Patent Office's esp@cenet and the World Intellectual Property Organization's PATENTSCOPE[1].

Global Dossier and International Filings

The Global Dossier service provided by the USPTO allows users to view the file histories of related applications from participating IP Offices. This can help in identifying similar patents filed in other jurisdictions and understanding the global patent family for this invention[1].

Economic and Technological Impact

Market Significance

The economic impact of US 9,669,021 can be significant, especially in the pharmaceutical market. The patent protects a novel method of treating Parkinson's disease, which could lead to improved patient outcomes and market dominance for the patent holder.

Technological Advancements

The technological advancements described in the patent, such as the development of a sublingual film for apomorphine delivery, contribute to the broader field of pharmaceuticals and drug delivery systems. This innovation can inspire further research and development in related areas.

Legal Considerations

Patent Enforcement and Litigation

Enforcing the patent involves ensuring that others do not infringe on the protected claims. This may involve litigation if another entity is found to be using a similar method or composition without permission.

Small Claims Patent Court

In the context of patent litigation, the concept of a small claims patent court, as studied by the Administrative Conference of the United States (ACUS), could potentially simplify and reduce the costs associated with patent disputes for smaller entities[2].

Data and Statistics

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents, including those related to pharmaceutical inventions. This dataset can be used to analyze trends and patterns in patenting activity, including the scope and claims of patents like US 9,669,021[3].

County-Level Patent Data

County-level patent data, as provided by the National Science Foundation, can help in understanding the geographical distribution of patenting activity. This data can be useful in identifying regions with high innovation activity in the pharmaceutical sector[4].

Key Takeaways

  • Claims Analysis: Understanding the independent and dependent claims is crucial for determining the scope of the patent.
  • Patent Scope: The scope includes the composition, method of use, and manufacturing process.
  • Prior Art: Reviewing prior art and related patents is essential for understanding the novelty and non-obviousness of the invention.
  • Global Dossier: Utilizing the Global Dossier service can provide insights into international filings and the global patent family.
  • Economic and Technological Impact: The patent has significant market and technological implications.
  • Legal Considerations: Enforcement and potential litigation are critical aspects of patent management.

FAQs

Q: What is the main subject of United States Patent 9,669,021?

A: The main subject is a method and composition for treating Parkinson's disease using a sublingual apomorphine film.

Q: How can I search for related patents?

A: You can use the USPTO's Patent Public Search tool or international databases like esp@cenet and PATENTSCOPE.

Q: What is the significance of the Global Dossier service?

A: The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, providing insights into the global patent family.

Q: How does the patent impact the pharmaceutical market?

A: The patent protects a novel method of treating Parkinson's disease, which could lead to improved patient outcomes and market dominance for the patent holder.

Q: What resources are available for analyzing patent claims and scope?

A: Resources include the USPTO's Patent Claims Research Dataset and county-level patent data from the National Science Foundation.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NSF - Invention, Knowledge Transfer, and Innovation: https://ncses.nsf.gov/pubs/nsb20224/technical-appendix
  5. Google Patents - US9669021B2: https://patents.google.com/patent/US9669021B2/en

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,669,021

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-001 May 21, 2020 DISCN Yes No 9,669,021 ⤷  Subscribe TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-002 May 21, 2020 DISCN Yes No 9,669,021 ⤷  Subscribe TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-003 May 21, 2020 DISCN Yes No 9,669,021 ⤷  Subscribe TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-004 May 21, 2020 DISCN Yes No 9,669,021 ⤷  Subscribe TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE ⤷  Subscribe
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-005 May 21, 2020 DISCN Yes No 9,669,021 ⤷  Subscribe TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,669,021

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2010259971 ⤷  Subscribe
Australia 2017200329 ⤷  Subscribe
Australia 2019200308 ⤷  Subscribe
Australia 2021201259 ⤷  Subscribe
Brazil 112012000204 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.